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Crosstalk between Keratinocytes and T Cells in a 3D
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Skin Diseases
Ellen H. van den Bogaard1,3, Geuranne S. Tjabringa1,3, Irma Joosten2, Mieke Vonk-Bergers1,
Esther van Rijssen2, Henk J. Tijssen2, Mirthe Erkens1, Joost Schalkwijk1,4 and Hans J.P.M. Koenen2,4
The interaction between keratinocytes and immune cells plays a major role in the development of inflammatory
skin diseases like psoriasis and atopic dermatitis. Pharmacological intervention to inhibit T cell–derived
proinflammatory mediators is an effective therapy in the treatment of psoriasis. Here, we present a model to
study the interaction between keratinocytes and T cells in a three-dimensional (3D) microenvironment, based on
human skin equivalents populated with CD4þ T cells. T cell migration into the dermis initiated keratinocyte
activation within 2 days, with hallmarks of a psoriasiform inflammation after 4 days. Expression of epidermal
psoriasis marker genes was upregulated, and proinflammatory cytokines and chemokines were highly expressed.
Disturbed epidermal differentiation was shown by downregulated filaggrin expression and involucrin expression
in the spinous layer. These effects were mediated via soluble factors produced by the T cells. The psoriasiform
inflammation was also observed using T helper type 1 (Th1)- and Th17-polarized CD4þ T cells. We validated our
model by treatment with anti-inflammatory drugs that reduced the expression of proinflammatory cytokines and
chemokines and suppressed the psoriasiform inflammation. We propose that our T cell–driven inflammatory skin
equivalent model has potential to study the pathogenesis of inflammatory skin diseases and may serve as a
preclinical screening tool for anti-inflammatory drugs.
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INTRODUCTION
Inflammatory skin diseases such as psoriasis and atopic
dermatitis are highly prevalent and pose a significant burden
on patients. Our understanding of these diseases is greatly
advanced, but many aspects of their etiology and pathogenesis
are still unknown. Recent genetic studies now lead to an
emerging consensus that psoriasis and atopic dermatitis result
from gene polymorphisms related to immune and skin barrier
function (Palmer et al., 2006; Roberson and Bowcock, 2010;
Bergboer et al., 2012). The translation of genetic characteristics
to (immuno)biological function in these diseases is clearly a
challenge as suitable models will require the presence of both
keratinocytes and immune cells to study the crucial interaction
between these cellular components.
At present, crosstalk between keratinocytes and lympho-
cytes is studied in submerged co-cultures (Muhr et al., 2010;
Renne et al., 2010; Martin et al., 2012), but these models
are limited by the lack of a three-dimensional (3D)
microenvironment such as found in the skin. The generation
of a 3D human inflammatory skin model comprising both
keratinocytes and lymphocytes has many requirements such
as the correct geometry and spatial distribution of the cells, a
matrix that allows lymphocyte trafficking, and a culture
medium that allows adequate growth and survival of all cell
types involved. In the absence of clinical parameters
(erythema, itch), the readout relies on the quantification of
molecular markers of disease. In psoriasis, the changes in the
keratinocyte transcriptome are well documented with many
molecular markers described, including Ki67, cytokeratin 16
(KRT16), elafin (PI3), psoriasin (S100A7), MRP8 (S100A8), and
b-defensin-2 (DEFB4) (Suarez-Farinas et al., 2012; Tian et al.,
2012); for gene and protein nomenclature of molecular
markers used in this study, see Supplementary Table S1
online). In addition, proinflammatory cytokines and chemo-
kines such as IL-6, IL-8, CXCL10, and CCL2 are highly
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upregulated in psoriatic keratinocytes (reviewed in Nickoloff
et al., 2007). Disturbed terminal differentiation in psoriatic
plaques is witnessed by low levels of filaggrin, upregulated
involucrin expression (Bernard et al., 1988), and induction of
the LCE3 family members, e.g., LCE3A (Bergboer et al., 2011).
For atopic dermatitis, only few studies describe molecular
epidermal markers that discriminate between atopic dermatitis
and psoriasis, such as NELL2, TARC, and CA2 (Nomura et al.,
2003; Kamsteeg et al., 2010). Atopic dermatitis has been
associated with T helper type 2 (Th2) cytokines that are well
documented for their effects on epidermal differentiation. The
Th2-mediated inflammation reduces expression of epidermal
differentiation genes, filaggrin, involucrin, and loricrin (Kim
et al., 2008; Howell et al., 2009; van den Bogaard et al., 2013)
and induces eosinophil chemoattractants (e.g., CCL26) (Bao
et al., 2012).
Recently, in vitro cultured skin equivalents were success-
fully introduced in humanized mouse models and injection of
psoriatic immune cells induced inflammation in these skin
equivalents (Guerrero-Aspizua et al., 2010; Carretero et al.,
2013), recapitulating features of psoriasis. However, the low-
throughput, high costs, and ethical considerations of animal
experimentation limits the use of these models for drug
development. Inflammatory skin equivalents using disease-
associated cytokines have been successfully developed by our
group (Tjabringa et al., 2008; Kamsteeg et al., 2011), but these
models lack the presence of immune cells. Attempts to
generate in vitro human skin equivalents with immune cells
resulted in human skin equivalents populated with Langerhans
cells or dermal dendritic cells to study skin sensitization (Rees
et al., 2011).
In our current work, we report on the successful population
of 3D skin equivalents with activated CD4þ T cells and Th1-
and Th17-polarized T cells. These T-cell subsets and their
cytokines are strongly associated with psoriasis pathology. We
studied the crosstalk between the T cells and keratinocytes at
the mRNA and protein levels upon direct and indirect contact
between both cellular compartments. The keratinocyte tran-
scriptome was indicative of a psoriasiform inflammation, and
anti-inflammatory drugs reduced the inflammatory phenotype.
This T cell–driven inflammatory skin equivalent model may aid
to study pathogenesis of inflammatory skin diseases and may
serve as a preclinical screening tool for anti-inflammatory drugs.
RESULTS
Migration of T cells in the dermis of human skin equivalents
To introduce T cells into the skin equivalents, fully developed
skin equivalents were lifted from the transwell system and
CD4þ T cells stimulated with anti-CD3/CD28 mAb-coated
beads (further referred to as T cells) were placed between the
transwell membrane and dermal side of the skin equivalents
(Figure 1a). The activation status of the T cells was confirmed
by flow cytometry (Supplementary Figure S1A online). We
started off by adding 2 106 CD4þ T cells and observed
T-cell migration in time, with T cells present in the dermis
from day 2 onwards (Figure 1b). However, as the epidermal
morphology was negatively affected at these high cell num-
bers (Figure 1c), we tested a concentration series and observed
that with numbers as low as 0.25106, T cells could still be
demonstrated in the dermis, whereas epidermal morphology
was preserved (Figure 1d). Activated T cells, just before
addition to the skin equivalents, were able to produce IFN-g,
tumor necrosis factor-a (TNF-a), IL-17, and IL-22 (Figure 1e),
but not IL-4 and IL-5 (data not shown). Nonactivated CD4þ T
cells were unable to migrate and populate the dermis
(Supplementary Figure S1B online). After 2 and 4 days of
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Figure 1. Activated CD4þ T cells migrate into skin equivalents. (a) The skin equivalents are lifted from the transwell support and T cells are placed
underneath the dermis. (b) CD4 immunostaining of migrating T cells. Images are representative of n¼2 individual experiments. Bar¼100mm. (c) Epidermal
morphology of skin equivalents with 2 106 T cells at day 4 after T cell administration. Representative image of n¼ 3 individual experiments. Bar¼50mm.
H&E, hematoxylin and eosin. (d) Epidermal morphology of skin equivalents with 0.25106 T cells. Arrows indicate T cells in the dermis. Representative
image of n¼3 individual experiments. Bar¼ 50mm. (e) Cytokine levels produced by the T cells just before addition to the skin equivalents, and after stimulation
with anti-CD3/CD28 beads (n¼5 T-cell donors; mean±SEM). TNF-a, tumor necrosis factor-a.
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migration, we analyzed the gene expression levels of the T
cells in the dermis of the skin equivalents and observed that the
expression of proinflammatory cytokines was highest at 2 days
of migration, and IFNG expression was relatively most abun-
dant as compared with IL17, IL22, and TNF (Supplementary
Figure S1C online).
Activated CD4þ T cells induce an activated, inflammatory
phenotype in epidermal cells
After administration of 0.25106 T cells to the skin equiva-
lents (day 0), molecular markers of epidermal inflammation
were determined at days 2 and 4 by quantitative PCR analysis.
We found a time-dependent induction of the psoriasis-asso-
ciated genes DEFB4, PI3, and LCE3A, whereas KRT16 and
S100A7 reached a plateau at day 2 (Figure 2a and b).
Molecular markers of atopic dermatitis, CA2 and NELL2, were
not induced (data not shown). Proinflammatory cytokine and
chemokine production by the keratinocytes reached a max-
imum at day 2 (Figure 2c). Immunostaining of the inflamma-
tory skin equivalents confirmed the mRNA expression data,
showing induced expression of psoriasis-associated proteins
hBD2, KRT16, and elafin (Figure 2d). As psoriatic skin is
characterized by increased proliferation and disturbed differ-
entiation, we analyzed these parameters in our model. The
terminal differentiation process was clearly disturbed, as seen
by reduced filaggrin expression and increased involucrin
expression in the stratum spinosum (Figure 2e). However,
Ki67 expression at the mRNA (Figure 2f) and protein levels
(data not shown) was unaffected and no signs of acanthosis or
hyperkeratosis were observed.
Direct contact is not absolutely required for crosstalk between
keratinocytes and T cells
To address the question of whether the inflammatory pheno-
type is caused by direct contact between T cells and the skin
equivalent or whether soluble factors produced by these cells
suffice, we exposed skin equivalents to 0.25 106 T cells
placed in the lower chamber of a transwell system (indirect) or
allowed T cells to migrate into the dermis of the skin
equivalents (direct). Only upon direct but not indirect contact,
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Figure 2. Epidermal response to T cells represents a psoriasiform phenotype. Keratinocyte mRNA expression levels of (a) DEFB4 and (b) other psoriasis-associated
genes in the epidermis after 2 and 4 days of 0.25 106 T-cell migration. (c) mRNA expression levels of proinflammatory cytokines and chemokines by
keratinocytes after 2 days and 4 days of T-cell migration. (d) Immunostaining of psoriasis-associated proteins hBD2, KRT16, and elafin after 2 and 4 days of T-cell
migration. Bar¼100mm. (e) Epidermal differentiation proteins filaggrin and involucrin demonstrated by immunostaining. Bar¼ 100mm. (f) Ki67 mRNA levels of
control and T cell–populated skin equivalents (for all mRNA data: n¼5 T-cell donors in 2 independent experiments, n¼ 2 keratinocyte donors; mean±SEM;
*Po0.05, **Po0.01 relative to control skin equivalents).
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we observed epidermal inflammation as exemplified by the
induced expression of psoriasis-associated marker genes
DEFB4 (Figure 3a), LCE3A, PI3, KRT16, and others
(Figure 3b) and the expression of proinflammatory cytokines
IL6, IL8, and IL23 (Figure 3c). Of interest, upon indirect
contact with the T cells, CCL2 and CXCL10 expression was
highly upregulated in keratinocytes (Figure 3d). This would
indicate that the T cells, through soluble factors, can activate
keratinocytes to produce chemokines. We then wondered
whether the relatively low cell numbers, and the associated
concentration gradient of the proinflammatory mediators
produced by the T cells, might have been a limiting factor
with regard to the lack of disease marker expression. There-
fore, we increased the number of T cells to 2 106 in the
lower chamber. Although the epidermal morphology was still
not affected, epidermal inflammation was instigated with
upregulation of all investigated psoriasis-associated markers
(Figure 3e and f) and proinflammatory cytokine expression
(Figure 3g). As soluble factors produced by the T cells appear
to be the main factor responsible for the inflammatory
phenotype in our model, we measured the cytokine levels in
the culture medium after 4 days of co-culture with skin
equivalents. Indeed, higher levels of IFN-g, IL-6, IL-22, IL-
17, and TNF-a were associated with higher T-cell numbers
(Figure 3h). The Th2 cytokines IL-4 and IL-5 were undetect-
able at either T-cell concentration, which could well
clarify the lack of an atopic dermatitis phenotype in our
model.
Th1- and Th17-polarized CD4þ T cells elicit psoriasis-like
epidermal inflammation
Our skin equivalents populated with T cells express many
molecular markers associated with psoriasis. As it is
commonly accepted that psoriasis is a Th1/Th17-mediated
disease, we used in vitro polarized Th1 and Th17 cells to
populate the skin equivalents. To this end, we cultured naive
CD4þ T cells under Th1- or Th17-polarizing conditions
during 5 days using well-established cytokine and blocking
antibody cocktails (Koenen et al., 2008). Following T-cell
polarization, the activation status, which is vital for migration,
as well as cytokine expression of the polarized cells, was
analyzed. All cultured T cells were proven activated based on
CD69 expression (Supplementary Figure S2A online). As
compared with activated T cells cultured for 5 days in the
absence of polarizing cytokines/antibodies (referred to as
nonpolarized T cells), the Th1-polarized cells showed clear
induction of IFNG with a loss of IL4 and IL17A (Figure 4a). In
the Th17-polarized cells, IL17A/F and IL22 was induced,
whereas IL4 expression was repressed. The IL17A expression
in Th17-polarized cells was confirmed at the protein level
(Figure 4b). We also attempted to include polarized Th2 cells.
Although these cells showed downregulated expression of
IFNG, IL17A/F, and IL22 (Figure 4b), no expression of the Th2
cytokine IL4 was induced. At 4 days after T-cell administra-
tion, the skin equivalents exposed to nonpolarized and Th1-,
Th17-, or Th2-polarized cells were analyzed for signs of
inflammation at the mRNA and protein levels. The Th1- and
Th17-polarized T cells, but not nonpolarized or Th2 cells
(Supplementary Figure S2C online), significantly induced
DEFB4 and LCE3A (Figure 4c) and CXCL10 chemokine
(Figure 4d) expression. In addition, a trend for upregulated
PI3 and KRT16 was observed, but this was not statistically
significant (Supplementary Figure S2B online). Induction of
hBD2 and KRT16 was confirmed at the protein level by
immunostaining (Figure 4e). Reduced filaggrin expression and
spinous cell expression of involucrin indicated disturbed
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Figure 3. Crosstalk between T cells and keratinocytes upon indirect contact. Activated 0.25 106 T cells were allowed to migrate into the skin equivalents
(direct contact) or placed in the lower chamber of the transwell system (indirect contact) for 4 days. Keratinocyte mRNA expression levels of (a) DEFB4,
(b) other psoriasis-associated genes, (c) pro-inflammatory cytokines, and (d) chemokines upon indirect and direct contact. Keratinocyte mRNA levels of (e, f)
psoriasis-associated genes and (g) proinflammatory cytokine expression when 2 106 T cells are used in the indirect model as compared with 0.25 106 T cells.
(h) Proinflammatory cytokine levels measured in the culture medium of the indirect model after 4 days of co-culture with 2106 T cells by Luminex (for all
figures, n¼3 T-cell donors; mean±SEM; *Po0.05, **Po0.01, and ***Po0.001). TNF-a, tumor necrosis factor-a.
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epidermal differentiation in the Th1- and Th17-polarized
inflammatory skin equivalents (Supplementary Figure S2D
online).
Anti-inflammatory drugs counteract the epidermal inflammatory
phenotype
To further validate our T cell–based inflammatory 3D skin
model, we studied the effect of targeting either the epidermal
compartment by all-trans-retinoic acid (ATRA) or the T-cell
compartment by cyclosporin A (CsA). Based on the initial
experiments where disease markers were found to be induced
after 2 days of T cell migration, we allowed T cells (as used in
Figure 2) to migrate for 2 days. Subsequently, the culture
medium was supplemented with ATRA or CsA and the culture
was continued for another 2 days. Psoriasis-associated genes
DEFB4, PI3, and S100A8 were found to be downregulated
upon treatment with either ATRA or CsA (Figure 5a). We also
observed the same trend for LCE3A and to a lesser extent
KRT16, but this decrease was not statistically significant
(Supplementary Figure S2E online). Protein expression analysis
of hBD2 and elafin confirmed the effect of ATRA or CsA on
the inflamed skin equivalents, showing reduced expression of
both proteins upon treatment. The expression of filaggrin was
partially restored upon CsA treatment (Figure 5b). To deter-
mine the treatment effects on the proinflammatory mediators
present in our model, we measured cytokine levels in the
conditioned medium from the inflammatory skin equivalents.
IL-17A and IL-22 levels were reduced upon treatment with
ATRA and CsA, whereas IFN-g was only affected by CsA
treatment (Figure 5c). Again, Th2 cytokines IL-4 and IL-5 were
undetectable in all experimental conditions (data not shown).
CXLC10 and CCL2 chemokine expression by the keratinocytes
was only reduced upon CsA treatment (Figure 5d). In addition,
we used the antipsoriatic drug Infliximab (TNF-a antibody) to
target the TNF-a produced by either the T cells or keratino-
cytes in our model, and found significantly reduced expression
levels of TNF, DEFB4, and CXCL8 and a similar trend to
S100A8, CXCL10, and CCL2 (Supplementary Figure S2F
online).
DISCUSSION
Recent studies combining transcriptomics data from psoriasis
and healthy skin resulted in a consensus molecular profile,
giving us more insight in the disease pathogenesis (Suarez-
Farinas et al., 2012; Tian et al., 2012). These molecular
markers of disease are highly valuable for validating in vitro
disease models as presented here. Many of the top 50 of
upregulated genes in psoriatic lesions are also upregulated in
our model such as DEFB4, PI3, IL8, S100A7, and more. In
addition, the protein expression was similar to psoriatic skin
with increased levels of the aforementioned molecular
markers and induced keratin 16 protein expression, which is
typical for hyperproliferative disorders such as psoriasis (Leigh
et al., 1995). The key feature of hyperproliferative skin
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Figure 5. Anti-inflammatory drugs target crosstalk and reduce the inflammatory phenotype. CD4þCD25 T cells were activated by anti-CD/CD28 bead
stimulation for 5 hours and allowed to migrate into the skin equivalents for 2 days to initiate inflammation. Thereafter, the culture medium was supplemented with
cyclosporine A (CsA) or all-trans-retinoic acid (ATRA) for another 2 days. (a) Keratinocyte mRNA expression levels of the psoriasis-associated genes DEFB4, PI3,
and S100A8 in untreated (T cell) and ATRA-, and CsA-treated inflammatory skin equivalents (n¼3 T-cell donors; mean±SEM; *Po0.05, **Po0.01, and
***Po0.001). (b) Immunostaining of hBD2 and elafin and filaggrin protein before (T cell) and after ATRA or CsA treatment. Bar¼100mm. (c) Cytokine levels
of IL-17A, IL-22, IFN-g, and IL-6 in the culture medium of the skin equivalents (n¼ 3 T-cell donors; mean±SEM; *Po0.05, **Po0.01, ***Po0.001).
(d) Keratinocyte mRNA levels of CXCL10 and CCL2 (n¼ 3 T-cell donors; mean±SEM; *Po0.05, **Po0.01, and ***Po0.001).
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disorders such as psoriasis is a thickened epidermis with high
numbers of Ki67-positive cells in the basal and suprabasal
layers. We did not observe this feature in our model. IL-22 has
been shown to be critical for epidermal hyperproliferation in
mouse models (Zheng et al., 2007; Wang et al., 2013),
submerged keratinocytes cultures (Mitra et al., 2012), and
skin equivalents stimulated with IL-22 showed acanthosis
(Boniface et al., 2005; Sa et al., 2007). The concentration of
IL-22 used to stimulate the skin equivalents was, however, 40-
fold higher than we measured in our model. In addition, the
previously reported acanthosis was a result from epidermal
hyperplasia and not from increased proliferation (Boniface
et al., 2005). Apparently, the crucial mediator(s) that cause
keratinocyte proliferation are lacking in our model and
peripheral blood–derived CD4þ T cells and the soluble
mediators they produce (e.g., IFN-g, TNF-a, IL-22, or IL-17)
are probably not the main instigators of epidermal hyperpro-
liferation. Alternatively, an excess of growth-inhibitory mole-
cules may be present (e.g.. transforming growth factor-b). In
addition, Ki67 expression levels of our skin equivalent model
when compared with normal skin in vivo indicate that the skin
equivalents still have a high proliferation rate after a culture
period of 14 days (data not shown). Perhaps this could explain
why we were not able to induce proliferation as the prolifera-
tion rate was already high. It could be expected that upon a
longer culture period of our normal skin equivalents (e.g., 3 to
4 weeks), the proliferation rate will lower, and then the T cells
may be capable of inducing keratinocyte hyperproliferation.
Obviously, several other potentially relevant cell types such as
fibroblasts, dendritic cells, endothelial cells, and mast cells are
absent here, some of which may be pivotal in promoting
keratinocyte proliferation.
The main goal of our study was to develop a model for the
crosstalk between T cells and keratinocytes in a 3D micro-
environment. This type of crosstalk is an essential feature in
disease pathogenesis, as immune cells produce mediators to
activate keratinocytes that in turn modulate the expression of
skin-homing markers on T cells (Gunther et al., 2005; McCully
et al., 2012) and produce chemokines to attract immune cells
(Giustizieri et al., 2001; Peters et al., 2013), thereby
completing the vicious circle of chronic inflammation. Here,
we have demonstrated such crosstalk by the induction of
keratinocyte-derived chemokines (Figure 3d) in response to
soluble factors produced by peripheral blood–derived CD4þ
T cells. In our indirect model using low number of T cells, this
chemokine production appeared to be the initial step in
epidermal activation as proinflammatory cytokine levels and
epidermal disease markers (e.g., DEFB4, KRT16) were unde-
tectable. Comparing the levels of soluble factors produced by
the T cells in our skin equivalent model with the concentra-
tions used in previous studies (Tjabringa et al., 2008) indicates
that the T cells produce a wider variety of cytokines but at
lower concentrations (data not shown). This suggests that our
T cell–driven inflammatory skin model is probably more
physiologically relevant than using an overload of cytokines
to stimulate skin equivalents.
Using polarized T cells, we aimed to generate inflammatory
skin equivalents with a disease phenotype specific for the
subset of helper T cells introduced in the skin equivalents. For
Th1- and Th17-polarized cells, this was successful as shown
by the induction of molecular markers for psoriasis, even
though we did not observe hyperproliferation or acanthosis.
The epidermal inflammation observed by addition of activated
T cells was similar to that of Th1- or Th17-skewed T cells that
indicates that our T cell–populated skin equivalent model
represents a psoriasiform inflammation. Despite activation, the
5-day cultured, nonpolarized, or Th2-skewed T cells did not
induce any signs of epidermal inflammation and we did not
detect any of these cells in the dermis of our skin equivalents
(data not shown). In addition, the keratinocytes did not
respond to these cells as shown by the lack of chemokine
production (Figure 4d), which appeared to be the initial step in
the inflammatory process in our model, as discussed above.
The lack of chemokine production could be an explanation for
the absence of T cells in the dermis of the skin equivalents,
and also demonstrates the importance of crosstalk between
the cellular compartments.
The inflammatory phenotype of our skin equivalents rather
resembled psoriasis than atopic dermatitis. Molecular
markers of atopic dermatitis (CA2 and NELL2) (Kamsteeg
et al., 2010) and morphological features such as spon-
giosis and/or apoptosis (Trautmann et al., 2000) were absent,
likely because of lack of IL-4 and IL-5 production by the T
cells. To generate a more atopic dermatitis-like phenotype,
we cultured naive CD4þ T cells under Th2-polarizing
conditions and added these to our skin equivalents. The Th2
polarization protocol led to downregulation of Th1- and Th17-
associated genes, but the cells failed to demonstrate
IL-4 upregulation (Figure 4a). Thus, so far, to study atopic
dermatitis pathogenesis and therapeutic intervention in vitro,
we are still limited to cytokine-stimulated skin equivalents
(van den Bogaard et al., 2013).
The use of patient-derived keratinocytes and T cells or skin-
resident T cells would be a valuable application of our model.
Humanized mouse models based on the initial studies using
the severe combined immunodeficient mouse xenograft
model (Nickoloff et al., 1995) have been crucial for our
current knowledge of psoriasis pathogenesis. Many
pathophysiological pathways and therapeutic strategies have
been elucidated by xenografting human skin and immune
cells from healthy volunteers or psoriasis patients onto
immunodeficient mice or mice deficient in type I and type II
IFN receptors (Gilhar et al., 2002; Boyman et al., 2004; Ma
et al., 2008). It would be very interesting to study if our model
has the potential to partially replace these models by using
patient-derived keratinocytes versus healthy immune cells and
vice versa. As the in vivo models all show hyperproliferation
and acanthosis, this might tackle the problem in our model
where these features are absent.
In lesional psoriatic skin, CD4þ T cells (as we studied in
our model) are mainly localized to the dermis, whereas
CD8þ T cells are present in the epidermis. The role of
CD8þ T cells in the epidermis and in psoriasis pathogenesis
is of current interest (Di Meglio and Duarte, 2013; Hijnen
et al., 2013). Therefore, we are in the process of introducing
CD8þ T cells to our model system. Entrance of these cells in
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the epidermal compartment would be biologically relevant and
would enable studying the role of these cells in the pathogenesis
of psoriasis. In addition, the implementation of other types of
immune cells in our model like natural killer cells and dendritic
cells would also be of interest as these cell types play an
important role in the development of psoriasis (reviewed in
Guttman-Yassky et al., 2011). Initial experiments incorporating
both T cells and dendritic cells in our skin equivalents show
promising results and this is feed for future studies.
In summary, the here presented T cell–driven in vitro model
of skin inflammation faithfully mimics many characteristics of
epidermal psoriasiform inflammation. In this model, clinically
used drugs that target the crosstalk between keratinocytes and
T cells successfully reduced the inflammatory phenotype,
thereby supporting the notion that our model may serve as a
highly suitable platform for drug screening purposes in a
preclinical setting.
MATERIALS AND METHODS
Generation of human inflammatory skin equivalents
Human skin equivalents were generated using decellularized de-
epidermized dermis as described previously and seeded with 105
human primary keratinocytes (Tjabringa et al., 2008). After 7 days
of culture at the air–liquid interface, activated T cells obtained from
donors allogeneic to the skin were introduced in the skin equiva-
lents (Figure 1a). T-cell viability in the skin equivalents was
assessed by morphology and TUNEL staining. To study the effect
of CsA (400 ng ml 1; Novartis Pharmaceuticals, Arnhem, The
Netherlands), and ATRA (10 6 M; Sigma-Aldrich, Zwijndrecht,
The Netherlands), the drugs were administered 2 days after T-cell
migration. Infliximab was administered at 10 mg ml 1 at the time of
T-cell introduction.
T-cell isolation and stimulation
CD4þ T cells were purified from peripheral blood mononuclear cells
obtained from healthy blood donors by negative selection as
described previously (Koenen et al., 2008) and depleted from
CD25high regulatory T cells by CD25 magnetic-activated cell sorting
beads (MACS; Miltenyi-Biotec, Bergisch-Gladbach, Germany). Sorted
naive CD4þ T-cell populations were typically 498% pure. To
activate the T cells, they were subsequently stimulated with anti-CD3/
CD28-beads (Life Technologies, Breda, The Netherlands) at a T-cell/
bead ratio of 5:1 for 5 hours. Thereafter, the activated cells were
washed and taken in skin equivalent medium and added to the skin
equivalent.
T-cell polarization
For Th1, Th2, and Th17 polarization of T cells, isolated naive CD4þ
T cells were activated with anti-CD3/CD28 beads (T-cell/bead ratio of
5:1) and cultured for 5 days under Th1-, Th2-, and Th17-polarizing
conditions. The following human recombinant cytokines and anti-
human mAbs were used to polarize naive T cells: for Th1 polariza-
tion: IFN-g (Endogen, Etten-Leur, The Netherlands, 200 U ml 1), IL-12
(Life Technologies, 50 ng ml 1), and anti-IL-4 (R&D Biosciences,
Abingdon, UK 5mg ml 1); for Th2 polarization: IL-4 (R&D
Biosciences, 250 U ml 1) and anti-IFN-g (R&D Biosciences,
5mg ml 1); for Th17 polarization: IL-1b (Invitrogen, 50 ng ml 1), IL-
6 (R&D Biosciences,, Etten-Leur, The Netherlands 20 ng ml 1), and
anti-IL-4 plus anti-IFN-g. T-cell culture conditions were conducted as
reported previously (Koenen et al., 2008).
Transcriptional analysis
Epidermis was separated from the skin equivalents by dispase (Roche
Diagnostics, Almere, The Netherlands) treatment for 2 hours at 4 1C.
The mRNA isolation, subsequent complementary DNA generation,
and quantitative PCR was performed as previously described (de
Jongh et al., 2005). Using the comparative DDCt method and RPLP0
as reference gene, relative mRNA expression levels were calculated
(Livak and Schmittgen, 2001). Transcriptome analysis of polarized T
cells was performed using TaqMan quantitative PCR analysis
(TaqMan, Life Technologies) according to the manufacturer’s instruc-
tions using HPRT as a reference gene.
Histology and immunohistochemistry
Formalin-fixed human skin equivalents were processed for routine
histology. Sections were stained with hematoxylin–eosin or processed
for immunohistochemical staining using an indirect immunoperox-
idase technique with avidin biotin complex enhancement (Vector
Laboratories, Peterborough, UK). Antibodies used are depicted in
Supplementary Table S2 online).
Flow cytometry and antibodies
T cells were analyzed by five-color flow cytometry as described
previously (Koenen, et al., 2008) using antibodies depicted in
Supplementary Table S2 online.
Cytokine analysis by ELISA and Luminex
Human cytokines were determined in culture supernatants using the
Bio-Plex systems (Bio-Rad, Veenendaal, The Netherlands) and ELISA
(IL-22, R&D Systems, Abingdon, UK) according to the manufacturer’s
instructions.
Statistics
Data are given as mean±SEM of n¼ 3–5 biological replicates.
Statistical analysis of quantitative PCR data was performed on DCt
values using commercially available software (PASW Statistics 18,
Chicago, IL). One-way analysis of variance, followed by Bonferroni
post hoc testing, and two-sided paired t-tests were performed.
Po0.05 was considered statistically significant.
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